Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshiya Noguchi is active.

Publication


Featured researches published by Toshiya Noguchi.


Bioorganic & Medicinal Chemistry | 2009

Synthesis and structure-activity relationships of radicicol derivatives and WNT-5A expression inhibitory activity.

Hideki Shinonaga; Toshiya Noguchi; Akiko Ikeda; Mari Aoki; Natsuko Fujimoto; Akira Kawashima

WNT-5A, a secretory glycoprotein, is related to the proliferation of dermal papilla cells. To develop a hair-growth stimulant, we have been searching for inhibitors of WNT-5A expression. We identified radicicol (1) as an active compound, and synthesized several radicicol derivatives. Among them, 6,7-dihydro-10alpha-hydroxy radicicol (31) was found to function as a new potent WNT-5A expression inhibitor with relatively low toxicity and excellent stability.


Bioorganic & Medicinal Chemistry | 2002

Synthesis and antirheumatic activity of the metabolites of esonarimod.

Toshiya Noguchi; Akira Onodera; Kazuyuki Tomisawa; Miyuki Yamashita; Kimiyo Takeshita; Sadakazu Yokomori

We have developed esonarimod, (+/-)-2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid, as a new antirheumatic drug. Now we describe herein the preparation of the enantiomers of (+/-)-deacetylesonarimod, the pharmaceutically active metabolites of esonarimod, and comparison of their antirheumatic activities. No significant difference has been observed between the two enantiomers. In a pre-clinical study of esonarimod, other metabolites were detected in rat blood or urine. We also synthesized these compounds as authentic samples to analyze the human metabolites in clinical studies of esonarimod.


Heterocycles | 2002

Synthesis of dihydrothiophene derivatives as metabolites of esonarimod

Toshiya Noguchi; Akira Onodera; Kazuyuki Tomisawa; Sadakazu Yokomori

Three compounds with a dihydrothiophene ring were synthesized as authentic samples to analyze human metabolites of Esonarimod, which has been developed as a new antirheumatic drug.


Synthetic Communications | 2003

A Practical Procedure for the Synthesis of Esonarimod, (R,S)-2-Acetylthiomethyl-4- (4-methylphenyl)-4-oxobutanoic Acid, an Antirheumatic Agent. II

Toshiya Noguchi; Akira Onodera; Masato Ito; Mamoru Yoshida; Sadakazu Yokomori

Abstract An efficient large-scale synthesis of Esonarimod, (R,S)-2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (1), a new antirheumatic drug, was established. A small amount of water increased the yield of the Michael addition of thioacetic acid (4) to 2-methylene-4-(4-methylphenyl)-4-oxobutanoic acid (2) to give 1. Multikilogram amounts of 1 (over 25 kg) were successfully obtained using this procedure. In addition, this procedure was repeated nine times, and reproducible results were obtained. See Ref. [1]


Archive | 2005

Novel nitrogenous heterocyclic compounds and salts thereof

Taro Kiyoto; Yasuhiro Tsutsui; Tadashi Tanaka; Sumie Shimada; Nobuhiko Nomura; Toshiya Noguchi; Fumihito Ushiyama; Yasunobu Ushiki


Archive | 2006

NOVEL NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF

Taro Kiyoto; Tadashi Tanaka; Yasuhiro Tsutsui; Junichi Ando; Mai Motono; Yasuko Kawaguchi; Toshiya Noguchi; Yasunobu Ushiki; Fumihito Ushiyama; Hiroki Urabe


Archive | 2007

Novel heterocyclic compound or salt thereof and intermediate thereof

Taro Kiyoto; Junichi Ando; Tadashi Tanaka; Yasuhiro Tsutsui; Mai Yokotani; Toshiya Noguchi; Fumihito Ushiyama; Hiroki Urabe; Hiromasa Horikiri


Bioorganic & Medicinal Chemistry | 2003

Synthesis and structure-activity relationships of 5-phenylthiophenecarboxylic acid derivatives as antirheumatic agents

Toshiya Noguchi; Masahiro Hasegawa; Kazuyuki Tomisawa; Morihiro Mitsukuchi


Chemical & Pharmaceutical Bulletin | 2002

A practical procedure for the synthesis of esonarimod, (R, S)-2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid, an antirheumatic agent (Part 1)

Toshiya Noguchi; Akira Onodera; Kazuyuki Tomisawa; Sadakazu Yokomori


Archive | 2008

Naphthyridine derivative monohydrate and method for producing the same

Taro Kiyoto; Masahiro Takebayashi; Yasutaka Baba; Muneo Syoji; Toshiya Noguchi; Fumihito Ushiyama; Hiroki Urabe; Hiromasa Horikiri

Collaboration


Dive into the Toshiya Noguchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Taro Kiyoto

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hiroki Urabe

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Tadashi Tanaka

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Junichi Ando

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Yasunobu Ushiki

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akira Onodera

Taisho Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge